» Articles » PMID: 7889411

How Virus Induces a Rapid or Slow Onset Insulin-dependent Diabetes Mellitus in a Transgenic Model

Overview
Journal Immunity
Publisher Cell Press
Date 1994 Jun 1
PMID 7889411
Citations 102
Authors
Affiliations
Soon will be listed here.
Abstract

We developed two distinct transgenic mouse models in which virus induced insulin-dependent (type 1) diabetes mellitus (IDDM). In one of these lines, the unique viral transgene was expressed in the islets of Langerhans and also in the thymus, but in the other line, expression was only in the islets. Insertion and expression of the viral (self) gene, per se, did not lead to IDDM, (incidence < 5%). By contrast, induction of an anti-self (anti-viral) CD8+ CTL response to the same virus later in life caused IDDM (incidence < 90%) in both transgenic lines, although the kinetics and requirements for CD4 help, the affinity and avidity of CD8+ CTL differed in each line. Mice not expressing the viral (self) gene in the thymus developed IDDM 10-14 days after infection. CD4+ T cells played no detectable role, since their depletion failed to alter either the kinetics or incidence of IDDM. By contrast, mice that expressed the viral gene in the thymus required significantly more time to develop IDDM. Their anti-self (viral) CD8+ CTL were of lower affinity and avidity than CD8+ CTL generated by nontransgenic controls. Disease was dependent on T cell help, since deletion of CD4+ cells completely circumvented the IDDM.

Citing Articles

Preclinical models for Type 1 Diabetes Mellitus - A practical approach for research.

Peng X, Rao G, Li X, Tong N, Tian Y, Fu X Int J Med Sci. 2023; 20(12):1644-1661.

PMID: 37859703 PMC: 10583179. DOI: 10.7150/ijms.86566.


Combination treatment of a novel CXCR3 antagonist ACT-777991 with an anti-CD3 antibody synergistically increases persistent remission in experimental models of type 1 diabetes.

Christen U, Pouzol L, Tunis M, Sassi A, Tondello C, Bayer M Clin Exp Immunol. 2023; 214(2):131-143.

PMID: 37458220 PMC: 10714188. DOI: 10.1093/cei/uxad083.


Chemokines as Drivers of the Autoimmune Destruction in Type 1 Diabetes: Opportunity for Therapeutic Intervention in Consideration of an Optimal Treatment Schedule.

Christen U, Kimmel R Front Endocrinol (Lausanne). 2020; 11:591083.

PMID: 33193102 PMC: 7604482. DOI: 10.3389/fendo.2020.591083.


Genetic Susceptibility of the Host in Virus-Induced Diabetes.

Mine K, Yoshikai Y, Takahashi H, Mori H, Anzai K, Nagafuchi S Microorganisms. 2020; 8(8).

PMID: 32727064 PMC: 7464158. DOI: 10.3390/microorganisms8081133.


Norovirus Changes Susceptibility to Type 1 Diabetes by Altering Intestinal Microbiota and Immune Cell Functions.

Pearson J, Tai N, Ekanayake-Alper D, Peng J, Hu Y, Hager K Front Immunol. 2019; 10:2654.

PMID: 31798584 PMC: 6863139. DOI: 10.3389/fimmu.2019.02654.